Intriguingly, Zheng et al. found that PD-L1+ expressed on TAMs correlated with better prognosis of HCC patients because TAMs-PD-L1+ tumors showed a high expression of genes involved in the immune responses and lymphocyte activation leading to anti-tumor activity in the TME [39]. The gene discussed is CD274; the disease is neoplasm.